Table 1 Statistical description indexes of H-T2 * (ms), L-T2* (ms), and SF (μg/l) before and after HSCT in TM patients.

From: Magnetic resonance imaging assessment of the changes of cardiac and hepatic iron load in thalassemia patients before and after hematopoietic stem cell transplantation

Variable

Group before (1)/after (2) HSCT

Frequency

Minimum value–Max value

Median

Interquartile range (P25%–P75%)

Mean ± standard deviation (\(\overline{x}\) ± s)

Mean change rate (%)

H-T2*

Overall 1

141

2.65–39.73

15.39

10.77–22.18

16.68 ± 8.55

19.63

Overall 2

141

2.15–48.66

19.36

12.12–26.50

19.95 ± 10.36

6-month 1

72

3.31–37.65

17.23

10.85–22.87

17.56 ± 8.49

6.43

6-month 2

72

3.84–42.79

18.07

11.57–24.72

18.69 ± 9.00

12-month 1

24

3.9–35.31

16.57

10.01–20.81

16.18 ± 8.17

3.37

12-month 2

24

4.35–34.65

14.87

8.43–22.21

16.72 ± 9.07

18-month 1

14

10.2–39.73

12.78

10.77–12.78

17.27 ± 9.31

41.49

18-month 2

14

6.55–48.66

26.56

13.09–34.46

24.44 ± 12.79

24-month 1

10

2.65–31.08

14.45

11.32–23.33

16.60 ± 9.30

23.85

24-month 2

10

2.15–30.96

24.46

15.68–25.45

20.56 ± 9.23

> 24 months 1

21

2.65–31.18

13.21

7.85–21.21

14.59 ± 8.68

69.19

> 24 months 2

21

4.32–48.66

26.71

14.40–33.30

24.69 ± 12.94

L-T2*

Overall 1

141

0.68–11.05

1.16

0.91–1.80

1.74 ± 1.67

7.19

Overall 2

141

0.72–6.99

1.24

0.99–2.23

1.86 ± 1.35

6-month 1

72

0.70–11.05

1.18

0.94–1.80

1.84 ± 1.90

− 10.30

6-month 2

72

0.75–5.77

1.16

0.99–1.92

1.65 ± 1.17

12-month 1

24

0.76–5.68

1.12

0.92–1.68

1.52 ± 1.05

− 0.99

12-month 2

24

0.86–5.53

1.26

1.00–1.78

1.51 ± 0.95

18-month 1

14

0.69–3.12

1.02

0.83–2.58

1.48 ± 0.93

13.84

18-month 2

14

0.72–6.99

0.98

0.83–2.22

1.69 ± 1.65

24-month 1

10

0.79–8.98

1.46

0.96–2.77

2.44 ± 2.57

− 0.62

24-month 2

10

0.86–4.78

0.96

0.79–1.85

2.42 ± 1.34

> 24 months 1

21

0.68–3.82

0.96

0.79–1.85

1.40 ± 0.93

93.73

> 24 months 2

21

0.85–6.99

2.37

1.25–3.86

2.71 ± 1.69

SF

Overall 1

141

295.00–14,724.50

4552

3278.76–4829.46

4529.55 ± 2535.92

57.14

Overall 2

141

563.72–30,605.05

7515

4246.62–8302.25

7117.74 ± 4120.65

6-month 1

72

295.00–14,724.50

4552

3228.58–5620.09

4827.90 ± 2953.06

57.93

6-month 2

72

1974.58–23,014.05

7718.73

4251.43–8489.25

7624.69 ± 4452.57

12-month 1

24

1661.11–14,463.08

4552

2895.79–6065.93

4925.36 ± 2583.75

73.84

12-month 2

24

3061.42–26,000.08

6996.115

4268.37–9316.36

8562.19 ± 6245.18

18-month 1

14

390.03–4552

4242.92

3882.28–4552

3951.25 ± 1093.78

128.51

18-month 2

14

563.72–30,605.05

6971

4887.96–7718.73

9028.83 ± 8410.68

24-month 1

10

1264.00–5894.69

4263.505

1678.86–4612.045

3660.10 ± 1615.46

40.34

24-month 2

10

925.00–9275.10

4224.495

2879.81–8117.56

5136.63 ± 2911.15

> 24 months 1

21

795.16–6086.13

4552

2936.25–4552

4007.80 ± 1410.98

85.47

> 24 months 2

21

1358.00–30,605.05

7636.95

4269.49–8011.62

7433.36 ± 5762.13

  1. H-T2* is Heart T2*; L-T2* is Liver T2*; SF is Serum Ferritin; HSCT is hematopoietic stem cell transplantation; TM is thalassemia.
Back to article page